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Abstract
Background: Asthma is the most common chronic inflammatory disorder in children. The aetiology of asthma
pathology is complex and highly heterogeneous, involving the interplay between genetic and environmental risk
factors that is hypothesized to involve epigenetic processes. Our aim was to explore whether methylomic variation
in early childhood is associated with discordance for asthma symptoms within monozygotic (MZ) twin pairs recruited
from the Environmental Risk (E-Risk) longitudinal twin study. We also aimed to identify differences in DNA methylation
that are associated with asthma that develops in childhood and persists into early adulthood as these may represent
useful prognostic biomarkers.
Results: We examined genome-wide patterns of DNA methylation in buccal cell samples collected from 37 MZ twin
pairs discordant for asthma at age 10. DNA methylation at individual CpG sites demonstrated significant variability
within discordant MZ twin pairs with the top-ranked nominally significant differentially methylated position (DMP)
located in the HGSNAT gene. We stratified our analysis by assessing DNA methylation differences in a sub-group of
MZ twin pairs who remained persistently discordant for asthma at age 18. The top-ranked nominally significant DMP
associated with persisting asthma is located in the vicinity of the HLX gene, which has been previously implicated in
childhood asthma.
Conclusions: We identified DNA methylation differences associated with childhood asthma in peripheral DNA samples
from discordant MZ twin pairs. Our data suggest that differences in DNA methylation associated with childhood
asthma which persists into early adulthood are distinct from those associated with asthma which remits.
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Background
Asthma is a common, complex and highly heterogeneous
disorder characterized by recurring episodes of breathless-
ness and wheezing [1]. Asthma affects approximately 235
million people worldwide and is the most prevalent chronic
inflammatory disorder in children [2]. The natural history
of childhood-onset asthma is complex; it is commonly
characterized by periods of remission and relapse [3, 4].
The heterogeneous features of asthma may indicate sub-
types of the disease with distinct molecular pathology [5, 6],
and recent analyses suggest that remitting and persistent
childhood-onset asthma is aetiologically distinct [7].
Currently, the diagnosis of asthma relies heavily on clinical
features [1]. Understanding the molecular mechanisms
involved in the onset and stability of asthma will facilitate
the identification of children at increased risk of developing
severe and persistent asthma in the future.
Asthma is known to involve complex interplay be-
tween genetic and environmental risk factors. Twin
studies have demonstrated that the aetiology of asthma
has a significant genetic contribution, with heritability
estimates ranging from 35 to 80 % [8–10]. Genome-wide
association studies (GWAS) have identified a small num-
ber of common risk variants robustly associated with
asthma, including a gene-rich locus on chromosome
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17q21 specific to childhood-onset disease [11]. Identified
variants, however, account for only a small proportion of
the estimated heritability [1, 11, 12]. Epidemiological
research also highlights associations between specific en-
vironmental exposures (including tobacco smoke [4, 13]
and microbial and viral agents [14, 15]) and the onset of
asthma, with exposures at certain critical periods during
early childhood being particularly important [1]. Recent
studies have started to examine the role of epigenetic
processes—acting to developmentally regulate gene ex-
pression via modifications to DNA, histone proteins and
chromatin—in complex disease phenotypes [16] includ-
ing asthma. A number of studies have identified locus-
specific variation in DNA methylation associated with
asthma pathogenesis [17–20]. One study linked differen-
tial DNA methylation in the vicinity of two candidate
genes (FOXP3 and IFNγ) with asthma in a study of N =
21 asthma-discordant adult monozygotic (MZ) twin
pairs [18]. A recent longitudinal study observed asthma-
related changes in DNA methylation at specific genetic
loci including IL4 and IL4R [17]. However, such pub-
lished research examining epigenetic variation in asthma
has primarily focused on candidate immune-related
genes; few studies have taken a genome-wide approach
[21]. Of note, a recent epigenome-wide methylation
study (EWAS) identified significant DNA methylation
changes at several loci associated with imunnunoglobu-
lin E (IgE) levels, which are known to correlate positively
with allergic diseases such as asthma [22]. However,
most patient samples have been cross-sectional and thus
it is unknown whether prior findings of methylomic dif-
ferences are differentially associated with persistent or
remitting asthma in early childhood.
The aim of the current study was to explore whether
methylomic variation in early childhood is associated
with discordance for asthma in 37 pairs of MZ twins.
We were interested in identifying differences in DNA
methylation that are associated with asthma that de-
velops in childhood and persists into early adulthood as
these may represent useful prognostic biomarkers. The
use of disease-discordant MZ twins represents a power-
ful strategy in epigenetic epidemiology because identi-
cal twins are matched for genotype, age, sex, maternal
environment, population cohort effects and exposure to
many shared environmental factors during childhood
[23]. We profiled DNA obtained from buccal swabs,
which have previously been used as a surrogate for
airway epithelial cells in DNA methylation studies [19].
Results
Brief overview of experimental approach
An overview of the methodological approach used in
this study is given in Additional file 1: Figure S1.
Briefly, we assessed genome-wide patterns of DNA
methylation in asthma-discordant MZ twins and
concordant unaffected MZ twins at age 10 using the
Illumina 450K HumanMethylation microarray (450K
array). Pre-processing, normalization and stringent
quality control were performed as previously de-
scribed [24] (see Methods for specific details). Our
analyses focused on identifying differentially methyl-
ated positions (DMPs) associated with asthma in (i)
all asthma-discordant MZ twins at age 10 (Additional
file 1: Figure S1A) and (ii) a sub-group with persist-
ent asthma who were discordant for asthma at age 10
and also at age 18 (Additional file 1: Figure S1B).
Using DNA previously collected at age 5, we subsequently
assessed longitudinal changes in DNA methylation
(between ages 5 and 10) in persistent-asthma-
discordant MZ twins (Additional file 1: Figure S1C).
Finally, we examined epigenetic variation at top-
ranked persistent-asthma-associated DMPs in (i) an
asthma-remission group, comprising of MZ twin pairs
discordant for asthma at age 10 but concordant for
no asthma phenotype at 18, and (ii) concordant un-
affected MZ twin pairs where neither twin had
asthma at both ages 10 and 18 (Additional file 1:
Figure S1D).
Differentially methylated positions at age 10 associated
with childhood asthma
Our primary focus was on within-pair DNA methyla-
tion differences detected at age 10, as an accurate diag-
nosis of asthma before age 5 is difficult [25, 26]. As
expected, within-twin patterns of DNA methylation
were highly correlated across all 37 MZ pairs (mean
within-twin r for DNA methylation across all 450K
array probes = 0.97) and no difference in overall mean
DNA methylation (calculated by averaging across all
probes on the 450K array) was observed between
affected and unaffected twins (P = 0.81), indicating that
childhood asthma is not associated with any global
changes in DNA methylation. In contrast, DNA methy-
lation at individual CpG sites demonstrated significant
variability within discordant MZ twin pairs. Table 1
lists the top-ranked nominally significant DMPs associ-
ated with asthma at age 10 (listing all with a nominal
P < 1 × 10−4). Although no DMP remained significant
after Bonferroni multiple test correction, permutation
analyses of the top-ranked loci revealed significant empir-
ical P values. Consistent within-twin differences in DNA
methylation were observed across the majority of discord-
ant MZ twin pairs (n = 37) for these top-ranked DMPs
(Fig. 1). The top-ranked DMP, cg03284554, located in
the promoter region of the heparan-α-glucosaminide
N-acetyltransferase (HGSNAT) gene on chromosome
8q21, was consistently hypermethylated in asthma-
affected twins compared to their unaffected co-twin
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Table 1 The top-ranked DMPs in asthma-discordant MZ twins
Probe ID Co-twin
mean
Asthma
mean
Mean Δβ P value Empirical
P value
Hg19 Relation to CpG
island
Gene region feature
category (UCSC)
Illumina gene
annotation
Probe
type
Gene annotation from GREAT
(distance from TSS)
cg03284554 0.178 0.218 0.041 6.87E-06 <0.0001 Chr8:43113670 N_Shore TSS1500 HGSNAT II HGSNAT (−1078)
cg01496463 0.761 0.795 0.034 1.80E-05 0.0002 Chr12:3262908 3′UTR TSPAN9 II PRMT8 (−207777), TSPAN9
(+206127)
cg04373937 0.836 0.859 0.023 4.26E-05 <0.0001 Chr14:29622576 Intergenic II G2E3 (−475503), PRKD1 (−155927)
cg14688104 0.035 0.038 0.003 4.29E-05 0.0001 Chr8:99508617 Island 1stExon; 5′UTR KCNS2 I KCNS2 (+192)
cg08158233 0.244 0.192 −0.052 5.36E-05 0.0001 Chr8:37470214 Intergenic II ZNF703 (−202244), KCNU1
(+709215)
cg17269596 0.581 0.637 0.056 5.49E-05 0.0004 Chr1:243061735 N_Shelf Intergenic II FAM36A (−3526)
cg14299157 0.813 0.756 −0.058 5.59E-05 <0.0001 Chr9:137272770 N_Shelf Intergenic II PPP1R26 (−238698), OLFM1
(+165861)
cg21201551 0.747 0.779 0.032 5.90E-05 0.0001 Chr1:31404820 S_Shelf Intergenic II PUM1 (−93670), NKAIN1 (+80500)
cg16414472 0.503 0.414 −0.089 6.05E-05 0.0002 Chr11:67866681 Body LRP5 I PPP6R3 (−118080), LRP5 (+29998)
cg01431063 0.057 0.072 0.014 8.92E-05 <0.0001 Chr10:115850893 Island Intergenic II TDRD1 (−78125), ADRB1 (+57098)
cg01048931 0.071 0.084 0.013 9.42E-05 <0.0001 Chr7:55639931 Island Body VOPP1 I VOPP1 (+268)
Ranked by P value. Empirical P value = (number of permutations which are at least as significant as the true result (P < 0.0001) divided by the number of permutations performed (n =10000))
DMPs differentially methylated positions, MZ monozygotic, GREAT Genomic Regions Enrichment of Annotations Tool, TSS transcription start site, UCSC University of California Santa Cruz genome browser
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(mean Δβ = 0.041, P = 6.87E-06, permuted empirical
P < 0.0001). Of note, HGSNAT gene expression is
down-regulated in paediatric allergic asthma cases com-
pared to controls [27]. Gene ontology (GO) term enrich-
ment analysis of the age-10 DMPs (see Additional file 2:
Table S1 for a list of included loci) identified 199 nomin-
ally significantly enriched terms (see Additional file 2:
Table S2), including categories related to anion/ion trans-
portation, regulation of ion transport (GO:0043269 (P =
0.0008), GO:0006811 (P = 0.003)) and regulation of anion
transport (GO:0044070 (P = 0.0026)). Interestingly, changes
in ion transport have previously been implicated in asthma
pathogenesis [28].
Methylomic profiling of MZ twins in a persistent-asthma
sub-group
Childhood asthma regularly remits in adolescence and
early adulthood [3, 4], with remitting and persistent child-
hood asthma potentially having differing aetiology [7]. We
therefore stratified our analysis by assessing age-10 DNA
methylation differences in a sub-group of MZ twin pairs
(n = 13 pairs) who remained persistently discordant for
asthma at age 18. Table 2 and Fig. 2 show the top-ranked
age-10 DMPs associated with asthma that persisted to age
18, which may represent useful childhood biomarkers of
prognosis. Again, no DMP remained significant after
Bonferroni correction, but empirical P values generated
Fig. 1 Graphs showing the difference in DNA methylation (Δβ) at age 10 between each pair of monozygotic (MZ) twins discordant for asthma
(affected twin − unaffected co-twin) for each of the ten top-ranked differentially methylated positions (DMPs). Mean within-twin pair Δβ across all
37 MZ twin pairs is highlighted in red. Error bars represent the ±standard deviation. Consistent within-twin pair differences in DNA methylation at
age 10 are observed across asthma-discordant MZ twin pairs at the top ten ranked differentially methylated positions
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Table 2 The top-ranked DMPs in age-10 MZ twins persistently discordant for asthma
Age 10 Age 5
Probe ID Co-twin
mean
Asthma
mean
Mean Δβ P value Empirical
P value
Mean Δβ P value Relation to
CpG island
Gene region feature
category (UCSC)
Hg19 Illumina gene
annotation
Probe
type
Gene annotation from GREAT
(distance from TSS)
cg23603194 0.289 0.180 −0.109 6.87E-06 0.0009 0.056 0.0519 N_Shore Intergenic Chr1:221060753 II HLX (+8011), DUSP10
(+854762)
cg27385757 0.353 0.286 −0.067 2.16E-05 0.0012 0.029 0.1966 S_Shore TSS1500; 3′UTR Chr6:30656024 KIAA1949;
NRM
II PPP1R18 (−932)
cg06483698 0.805 0.848 0.043 2.64E-05 0.0007 −0.006 0.6847 N_Shore Body Chr7:6310290 CYTH3 II CYTH3 (+1951), USP42
(+165741)
cg05895618 0.559 0.655 0.096 2.69E-05 0.0007 −0.026 0.5367 5′UTR Chr11:19222395 CSRP3 II CSRP3 (+1193), ZDHHC13
(+83704)
cg14868530 0.081 0.098 0.017 3.36E-05 0.0005 −0.008 0.0351 Island 5′UTR; 1stExon Chr15:73976679 CD276 I CD276 (+58)
cg21304454 0.530 0.392 −0.138 3.59E-05 0.0009 0.070 0.1223 N_Shelf Body Chr1:17302859 MFAP2 II MFAP2 (+4313), CROCC
(+54415)
cg11998205 0.853 0.806 −0.047 4.28E-05 0.0017 −0.033 0.0361 S_Shelf Body Chr19:48840527 TMEM143 I EMP3 (+11899), TMEM143
(+26658)
cg18513344 0.210 0.137 −0.072 4.39E-05 0.0007 −0.022 0.3459 Body Chr3:195531298 MUC4 II MUC4 (+7545), MUC20
(+83546)
cg08657206 0.256 0.221 −0.035 5.55E-05 0.0009 −0.005 0.7971 N_Shore Intergenic Chr1:180197901 I LHX4 (−1531)
cg19865472 0.897 0.844 −0.052 5.90E-05 0.0004 −0.065 0.1373 Island 3′UTR Chr19:617133 HCN2 I POLRMT (+16434), HCN2
(+27241)
cg26280666 0.0976 0.0717 −0.0259 6.13E-05 0.0009 −0.0115 0.4006 N_Shore Body Chr8:72755568 MSC II EYA1 (−486590), MSC (+1162)
cg13512987 0.5252 0.6452 0.1200 6.77E-05 0.0005 −0.0438 0.1137 5′UTR; 1stExon Chr12:6898785 CD4 II CD4 (+148)
cg24664347 0.7364 0.8161 0.0797 7.51E-05 0.0006 −0.0624 0.0007 S_Shore TSS1500 Chr8:86841010 REXO1L2P II REXO1L1 (−51705), PSKH2
(+240840)
cg25346117 0.6694 0.7450 0.0756 8.06E-05 0.0004 0.0030 0.8688 Body Chr1:116923256 ATP1A1 II ATP1A1 (+7462), CD58
(+190458)
cg09587549 0.2320 0.2647 0.0327 9.75E-05 0.0005 −0.0006 0.9742 Island 5′UTR; 1stExon Chr16:31214126 PYCARD I PYCARD (−30)
cg03225548 0.7651 0.6807 −0.0844 9.90E-05 0.0004 −0.0014 0.9638 N_Shelf Body; 5′UTR Chr18:71811234 FBXO15 II TIMM21 (−4511), FBXO15
(+3865)
cg17130754 0.7563 0.6967 −0.0597 9.99E-05 0.0004 0.0478 0.0739 Intergenic Chr10:3536341 II PITRM1 (−321309), KLF6
(+291131)
Ranked by P value. Empirical P value = (number of permutations which are at least as significant as the true result (P < 0.0001) divided by the number of permutations performed (n = 8192))
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from permutation analyses suggest that these represent
significant differences. The top-ranked DMP associated
with persisting asthma (cg23603194, located downstream
of the HLX gene) was consistently hypomethylated in
asthma-affected twins compared with their unaffected co-
twin (mean Δβ = −0.11, P = 6.87E-06, permuted empirical
P = 0.0009). Interestingly, a number of additional probes
(cg18788664, cg10975889, cg15730491) annotated to the
HLX gene region were also differentially methylated in
twins discordant for persistent asthma compared to their
unaffected co-twin (see Fig. 3). Of note, genetic variation
in this gene has been previously associated with the devel-
opment of childhood asthma [29, 30] and cytokine secre-
tion at birth [31]. We next tested the specificity of our
persistent-asthma-associated DMPs, by comparing aver-
age within-twin DNA methylation differences at these loci
in (i) an asthma-remission group, comprising of MZ twin
pairs discordant for asthma at age 10 but concordant for
Fig. 2 a Graphs showing the difference in DNA methylation (Δβ) at age 10 between each pair of monozygotic (MZ) twins persistently discordant
(at ages 10 and 18) for asthma (affected twin − unaffected co-twin) for each of the ten top-ranked differential methylated positions (DMPs). Mean
within-twin pair Δβ across all 13 MZ twin pairs is highlighted in red. Error bars represent the ±standard deviation. Consistent within-twin pair
differences in DNA methylation are observed across persistently discordant MZ twin pairs at the ten top-ranked DMPs. b Graph showing average
within-twin beta difference of (i) persistent-asthma-discordant MZ twins at age 10, (ii) asthma-remission sub-group (twins discordant for asthma
at age 10 but the affected twin had remitted at 18, n = 20 twin pairs) and the age-matched concordant unaffected MZ twins (19 twin pairs).
Average within-twin differences in DNA methylation are significantly larger at nine of the ten top-ranked DMPs in asthma-discordant twins
compared to both the asthma-remission sub-group and twins concordant for no asthma. Between group comparisons of average within-twin
beta differences were examined using a one-way ANOVA. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05
Fig. 3 A number of probes annotated to the HLX gene were significantly differentially methylated in persistent-asthma twins compared to their
unaffected co-twin. Asthma-associated differentially methylated positions are highlighted in red. Green bars denote the location of annotated CpG
islands. Of note, asthma-associated DMPs overlap known CpG islands downstream of the HLX gene. Δβ =mean within-twin beta difference
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no asthma phenotype at 18 (n = 20 twin pairs), and (ii)
concordant unaffected MZ twin pairs where neither twin
had asthma at both ages 10 and 18 (n = 19 twin pairs). At
nine of the ten top-ranked DMPs, average within-twin
differences in DNA methylation were significantly differ-
ent between groups (see Fig. 2b), with post hoc pairwise
comparisons indicating that average within-twin differ-
ences in DNA methylation are significantly larger at these
top-ranked DMPs in the persistent-asthma-discordant
twins compared to both the asthma-remission twin sub-
group and twins concordant for no asthma. GO term
enrichment analysis was undertaken on persistent age-10
asthma DMPs (nominal P < 0.001, see Additional file 2:
Table S3 for a list of loci included in the analysis). We
identified 142 enriched (nominal P < 0.05) terms (see
Additional file 2: Table S4), including categories related to
interleukin-2 (IL-2) processes (GO:0042094 (P = 0.0009),
GO:0032623 (P = 0.0025)) and type I interferon produc-
tion (GO:0032480 (P = 0.0039)). Of note, both IL-2 and
interferon pathways play an important role in cell-
mediated immunity [32, 33] and have previously been im-
plicated in asthma pathogenesis [34, 35].
Longitudinal DNA methylation changes in persistent-
asthma MZ twins
DNA methylation at the top-ranked age-10 persistent-
asthma DMPs (P < 0.0001) could be examined in
matched buccal cell DNA collected at age 5 for 11 of the
13 persistently discordant MZ twin pairs (2 pairs lacked
age-5 DNA methylation data). Although two of the top-
ranked probes (cg14868530 (annotated to CD276) and
cg11998205 (annotated to TMEM143)) were signifi-
cantly differentially methylated in the same direction be-
tween affected twins and their unaffected co-twin at age
5 (P = 0.035 and P = 0.036, respectively), no significant
differences at age 5 were observed for the other top-
ranked loci, and there was no overall correlation in
within-twin differences at ages 5 and 10 for the top-
ranked persistent-asthma DMPs. These findings suggest
that epigenetic variation associated with asthma persist-
ing through adolescence is not detectable in very early
childhood. Within our persistent-asthma sub-group, we
therefore next examined persistent-asthma-associated
intra-individual changes in DNA methylation between
ages 5 and 10. For each probe, we calculated the change
in DNA methylation from age 5 to age 10 (longitudinal
Δβ) for each individual and examined the difference in
longitudinal Δβ between affected twins and their un-
affected co-twin. The top-ranked probe (cg26090469),
located in AFF4, became significantly hypomethylated
from age 5 to age 10 in twins who developed persistent
asthma, compared to their unaffected co-twin (P =
1.41E-06, Table 3). GO term enrichment analysis was
performed for the genes associated with the asthma-
associated (nominal P < 0.001) intra-individual changes
in DNA methylation identified between ages 5 and 10
(see Additional file 2: Table S5 for a list of genes
included). This analysis identified 90 enriched (nominal
P < 0.05) terms (see Additional file 2: Table S6), with the
top-ranked categories being related to activin receptor
signalling (GO:0032926 (P = 0.0006), GO:0032925 (P =
0.005)) and epithelium development (GO:0060429 (P =
0.0006)).
Discussion
In this study, we first assessed genome-wide patterns of
DNA methylation in buccal cell samples collected from
37 asthma-discordant MZ twin pairs at age 10. We iden-
tified a number of asthma-associated DMPs, character-
ized by consistent within-pair differences in DNA
methylation. The top-ranked DMP (cg03284554) is lo-
cated upstream of HGSNAT, which has been previously
shown to be down-regulated in paediatric allergic
asthma [27]. We next stratified our analysis by assessing
DNA methylation differences in a sub-group of MZ twin
pairs who remained persistently discordant for asthma
8 years later, at age 18. The top-ranked DMP associated
with persisting asthma (cg23603194) is located 8 kb
downstream of the transcriptional start site (TSS) of the
HLX gene, which has been previously implicated in
childhood asthma [29, 30]. Moreover, a number of add-
itional probes (cg18788664, cg10975889, cg15730491)
located in the proximity of the HLX gene were signifi-
cantly differentially methylated in affected twins com-
pared to their unaffected co-twin. Although the majority
of these probes are located >8 kb downstream of the
HLX TSS, their proximity to annotated CpG islands (see
Fig. 3) suggests that they reside in potential regulatory
regions. HLX has been identified as an important regula-
tor of TH1 differentiation and a suppressor of TH2 com-
mitment, mediating pathways that are known to be
perturbed in asthma [29, 36]. The functional relevance
of DNA methylation changes downstream of the HLX
gene warrants further investigation.
Several other DMPs identified in the persistent-asthma
sub-group analysis are located in the vicinity of genes that
have previously been implicated in asthma. For example,
cg13512987, located in the first exon of the cluster of differ-
entiation 4 (CD4) gene, was significantly hypermethylated
in asthma-affected twins compared to their unaffected co-
twin. CD4 is a glycoprotein found on the surface of
immune cells such as T helper cells, monocytes, macro-
phages and dendritic cells [37]. CD4+ T cells are increased
in broncho–alveolar lavage fluid and bronchial biopsy spec-
imens from asthmatic patients [38]. Similarly, cg14868530,
which is hypermethylated in affected twins compared to
their unaffected co-twin, is located in the first exon of
CD276, a gene important for T cell proliferation [39].
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Furthermore, cg18513344, which we found to be hypo-
methylated in affected twins, is associated with MUC4, a
gene that encodes an airway mucin protein—a major con-
stituent of mucus [40]. Interestingly, evaluation of airway
biopsies from asthmatic patients have observed higher
MUC4 mRNA levels compared to normal healthy controls
[41]. DNA methylation studies in other complex pheno-
types report [42–44] similarly small absolute (<10 %) differ-
ences in DNA methylation to those observed in this study.
The DNA methylation values reported in this study
Table 3 The top-ranked CpG sites which show changes in DNA methylation levels overtime in the discordant MZ twins
Probe ID Co-twin
mean
Asthma
mean
Mean
Δβ
P value Hg19 Relation to
CpG island
Gene region
feature category
(UCSC)
Illumina gene
annotation
Probe
type
Gene annotation
from GREAT
(distance from TSS)
cg26090469 −0.0122 0.0341 0.0463 1.41E-06 Chr5:132271449 Body AFF4 II AFF4 (+27904),
LEAP2 (+62092)
cg02181624 0.1204 −0.0649 −0.1854 1.68E-06 Chr6:168716070 N_Shelf Body DACT2 II FRMD1 (−236232),
DACT2 (+4331)
cg17199800 −0.0902 0.0620 0.1522 9.47E-06 Chr7:96632777 N_Shore Body DLX6AS II DLX6 (−2512)
cg21875946 0.0892 −0.0276 −0.1168 1.88E-05 Chr1:206663985 Body IKBKE II RASSF5 (−16893),
IKBKE (+20400)
cg15691003 0.0082 −0.0205 −0.0287 3.26E-05 Chr1:22351864 N_Shore Body; TSS200 HSPC157 II CDC42 (−27255),
CELA3B (+48447)
cg02836325 −0.1285 −0.0153 0.1132 3.37E-05 Chr17:76403955 Body PGS1 II PGS1 (+29221),
DNAH17 (+169520)
cg16789707 −0.0958 0.0404 0.1362 4.33E-05 Chr16:88767723 S_Shelf Body RNF166 II SNAI3 (−14842),
RNF166 (+5105)
cg04313071 0.1063 −0.0249 −0.1312 4.33E-05 Chr14:102685619 Body WDR20 II HSP90AA1 (−79534),
MOK (+85911)
cg23847069 0.1153 −0.0057 −0.1210 4.79E-05 Chr17:2702204 Body RAP1GAP2 I RAP1GAP2 (+2473),
OR1D5 (+264696)
cg24293948 0.0646 −0.0729 −0.1375 5.04E-05 Chr18:61670413 S_Shore Intergenic II SERPINB8 (+33151),
LINC00305 (+95460)
cg06367321 0.1110 −0.0015 −0.1125 5.14E-05 Chr16:30125232 TSS200;
TSS1500
LOC100271831;
GDPD3
I GDPD3 (−355)
cg06655665 −0.1603 −0.0359 0.1243 5.45E-05 Chr2:38607629 S_Shelf Intergenic II ATL2 (−3198)
cg25406011 0.1312 −0.0175 −0.1487 6.04E-05 Chr11:1254421 Island Body MUC5B II MUC5B (+10127),
TOLLIP (+76470)
cg25494605 0.0873 −0.0652 −0.1525 6.55E-05 Chr5:173472097 TSS1500 HMP19 II HMP19 (−626)
cg24664347 −0.1381 0.0087 0.1468 6.88E-05 Chr8:86841010 S_Shore TSS1500 REXO1L2P II REXO1L1 (−51705),
PSKH2 (+240840)
cg18184910 0.2047 0.0402 −0.1644 7.10E-05 Chr6:47624247 TSS200 GPR111 II GPR111 (−78)
cg00840341 0.1094 0.0131 −0.0963 7.60E-05 Chr16:17609453 Intergenic II XYLT1 (−44716),
AK310228 (+825170)
cg14141399 0.2139 −0.0312 −0.2451 7.66E-05 Chr19:52228048 TSS1500 HAS1 II HAS1 (−828)
cg14179581 −0.1193 0.0758 0.1951 7.74E-05 Chr1:50881502 Island Intergenic II DMRTA2 (+7616),
ELAVL4 (+306909)
cg21209859 −0.0892 0.0351 0.1242 7.78E-05 Chr1:167682516 N_Shore Intergenic II CREG1 (−159461),
MPZL1 (−8670)
cg21187770 0.1265 −0.0432 −0.1697 8.57E-05 Chr2:26205876 S_Shore TSS1500 KIF3C I KIF3C (−434)
cg01382502 −0.1489 −0.0279 0.1210 8.96E-05 Chr16:22252504 Body EEF2K II POLR3E (−56236),
EEF2K (+34913)
cg09900436 −0.1813 0.0363 0.2175 8.96E-05 Chr20:58630954 TSS200 C20orf197 II CDH26 (+97484)
cg16606561 0.2193 0.0631 −0.1562 9.72E-05 Chr20:824641 N_Shore 5′UTR; TSS1500 FAM110A II FAM110A (+10286),
ANGPT4 (+72318)
cg15048437 0.0067 −0.0159 −0.0226 9.85E-05 Chr19:37019614 Island TSS1500 ZNF260 I ZNF260 (−367)
Ranked by P value
DMPs differentially methylated positions, MZ monozygotic, GREAT Genomic Regions Enrichment of Annotations Tool, TSS transcription start site, UCSC University of
California Santa Cruz
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represent aggregate values across all cells from a given sam-
ple. A shift in DNA methylation of 5–10 % indicates that
~5–10 % of DNA molecules in the population assessed be-
come fully methylated (or unmethylated) at that locus, with
potentially large functional consequences in that specific
cellular sub-population. Finally, GO analysis of differentially
methylated loci associated with a persistent-asthma pheno-
type revealed an enrichment of immune-related pathways
including IL-2 and interferon type I signalling pathways
which have previously been implicated in asthma pathogen-
esis [34, 35]. Together, our data suggest that epigenetic vari-
ation is associated with childhood asthma, and that
methylomic differences may potentially be useful markers
for predicting the persistence of asthma at age 18.
A recent EWAS analysis identified robust DNA methyla-
tion changes at several loci associated with imunnunoglo-
bulin E (IgE) levels, which are known to correlate positively
with allergic diseases such as asthma [22]. Two of the 69
IgE-associated DMPs (cg11398517 (P = 0.008),
cg16522484 (P = 0.04)) were nominally significantly
associated with asthma in our primary asthma-
discordant cohort (37 twin pairs). Also, 5 of the 69 IgE-
associated DMPs were nominally associated with asthma
in our persistently discordant MZ twins (cg08404225 (P =
0.003), cg05215575 (P = 0.014), cg09676390 (P = 0.019),
cg25494227 (P = 0.02), cg17749520 (P = 0.029)). These
DMPs were not associated with asthma in twin pairs
where the affected twin had remission of symptoms
by age 18, although several IgE-associated DMPs were
cg17890764 (P = 0.003), cg07374928 (P = 0.01) and
cg11398517 (P = 0.028); these DMPs may be associ-
ated with IgE levels in childhood asthma which re-
mits in early adulthood. Although our findings
require replication in larger independent prospective
asthma cohorts, the data suggest that prognostic
DNA methylation markers of persistent asthma may
be identified. It would be interesting to combine epi-
genetic data with polygenic risk scores, which have
previously been associated with life-course-persistent
asthma [7].
DNA methylation at the top-ranked age-10 persistent-
asthma DMPs (P < 0.0001) was examined in matched
buccal cell DNA collected at age 5 for 11 of the 13 per-
sistently discordant MZ twin pairs. Although there was
no overall correlation in within-twin differences at ages
5 and 10 for the top-ranked persistent-asthma DMPs,
we identified a number of age-10 DMPs that were also
nominally significantly differentially methylated in the
twins at age 5. These data suggest that DNA methylation
of these loci could potentially represent early biomarkers
for persistent asthma. We next examined asthma-
associated intra-individual changes in DNA methylation
between ages 5 and 10. The top-ranked longitudinal
DMP (cg26090469), which was significantly
hypomethylated from age 5 to age 10 in twins with per-
sistent asthma compared to their unaffected co-twin, is
located in the AFF4 gene. Research suggests that AFF4,
an important scaffold protein, may play a role in viral
gene expression [45]. Similarly, cg25406011, located in
exon 18 of the MUC5B gene, was significantly hypo-
methylated from age 5 to age 10 in twins with persistent
asthma compared to their unaffected co-twin. MUC5B
codes for the major gel-forming mucin in mucus. Re-
cently, it has been shown that mouse Muc5b is required
for mucociliary clearance, for controlling infections in
the airways and for immune homeostasis in mouse lungs
[46]. Our data suggests that site-specific longitudinal
intra-individual DNA methylation changes in MUC5B
may play a role in the pathogenesis and development of
asthma. Genes annotated to the most DMPs between
ages 5 and 10 in twins who develop persistent asthma
highlighted significant GO term enrichment for activin
receptor signalling and epithelium development. Not-
ably, activin signalling has previously been implicated in
airway remodelling in asthma [47].
Despite the power of the discordant MZ twin ap-
proach for epigenetic epidemiology, there are several
limitations to this study. First, an event history calendar
was used to record children’s history of chronic health
conditions at ages 5 and 10 and a set of seven asthma
symptoms were assessed to determine asthma status at
age 18. However, the questions used in this study are
well established and have been validated and used previ-
ously in studies of asthma and other childhood pheno-
types [48–51]. Second, our primary and secondary
analyses utilized a small cohort of 74 twin children (37
MZ pairs) and 26 twin children (13 MZ twin pairs), re-
spectively. Despite the modest sample size, the cases
were exhaustive of asthma-discordant pairs in our birth
cohort which has been shown to represent the UK popu-
lation [52]. Nevertheless, our analyses were relatively
underpowered to detect small changes in DNA methyla-
tion. Although no probe reaches Bonferroni-corrected
levels of significance, DNA methylation studies in other
complex phenotypes report similarly small absolute dif-
ferences. Given the known non-independence of DNA
methylation across the probes represented on the 450K
array [53], it is likely that conventional methods of glo-
bal statistical significance (which assume statistical inde-
pendence of the multiple tests) are not appropriate for
these analyses [54]. As an alternative approach, we
therefore report empirical P values (generated by ran-
domly re-assigning disease status and re-analysing the
data) for each of the top-ranked probes using permuta-
tion testing [54]. After up to 10,000 permutations, each
of our top-ranked probes was found to be significantly
associated with asthma at an empirical P < 0.0009. Third,
methylomic analysis was performed on DNA from
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buccal cells, which may not represent the primary target
tissue involved in asthma. However, buccal cells are an
easily accessible tissue that encompasses a portion of the
upper airway and have previously been proposed as a
surrogate for airway epithelial cells [19]. Due to the lim-
ited availability of buccal cell DNA, technical validation,
using bisulfite pyrosequencing, of our top-ranked DMPs
was not performed in this study. Of note, however, we
and others have previously validated small changes in
DNA methylation identified from the 450K array using
pyrosequencing, highlighting the reliability of the 450K
array [43, 55–57]. Our analysis of asthma-concordant
MZ twin pairs highlights the specificity of the differences
we observed in disease-discordant twin pairs. Addition-
ally, buccal cell RNA was not available for our MZ twin
cohort and thus we were unable to directly examine the
functional relevancy of asthma-associated DMPs on gene
expression. One final caveat in this study is that chorio-
nicity data were not available on these twins, a potential
limitation given that whether or not MZ twins share a
placenta may influence epigenomic and transcriptional
differences mediated by subtle differences in the prenatal
environment [58].
Conclusions
In summary, we have identified DNA methylation differ-
ences associated with childhood asthma in peripheral
DNA samples from discordant MZ twin pairs. The top-
ranked persistent-asthma-associated DMP (cg23603194)
identified in this study is downstream of the HLX gene
that has been previously implicated in the pathogenesis
of asthma. Our data suggest that differences in DNA
methylation associated with childhood asthma which
persists into early adulthood are distinct from those as-
sociated with childhood asthma which remits before
early adulthood.
Methods
Study cohort
Participants were recruited from the Environmental Risk
(E-Risk) longitudinal twin study, which tracks the devel-
opment of a birth cohort of 1116 British twin pairs (n =
2232 individuals). The sample was drawn from a larger
birth register of twins born in England and Wales in
1994–1995 [59]. Full details about the sample are re-
ported elsewhere [60]. The sample includes 55 % MZ
twin pairs. Sex is evenly distributed within zygosity
(49 % male). The sample was originally assessed when
the twins were aged 5, and follow-up home visits took
place when the children were aged 7 (98 % participa-
tion), 10 (96 % participation), 12 (96 % participation)
and 18 years (93 % participation). The Joint South
London and Maudsley and the Institute of Psychiatry
Research Ethics Committee approved each phase of the
study. Prior to age 18, parents gave informed consent
and children gave assent; at age 18, the participants
themselves gave informed consent.
Measures
At ages 5 and 10, information was collected from
mothers about each child’s asthma using an event his-
tory calendar for recording children’s history of chronic
health conditions. Methodological studies document that
event history calendars improve accuracy of health in-
formation over conventional questionnaire instruments
[48, 49]. A sub-sample of 56 Caucasian families (112 chil-
dren, 56 twin pairs) was used for this study, comprising
families who (a) had MZ twins, and (b) were discordant
for asthma at age 10 (37 twin pairs) or (c) both twins did
not have asthma (19 twin pairs). All MZ twins were
Caucasian and born in the UK. Buccal cell samples were
obtained from children during home visits at ages 5 and
10 (see Additional file 2: Table S7 for further details). Gen-
omic DNA was extracted from buccal cells using a stand-
ard procedure [61].
When the children were 18 years old, asthmatic symp-
toms were further assessed in a private individual inter-
view conducted by trained professionals. Three questions
were taken from the European Community Respiratory
Health Survey (ECRHS) II screening questionnaire
(www.ecrhs.org) [51] related to asthma (“Have you been
woken by an attack of shortness of breath at any time in
the last 12 months?”, “Have you had an attack of asthma
in the last 12 months?”, “Are you currently taking any
medicine (including inhalers, aerosols or tablets) for
asthma?”). A dichotomous variable representing children
who reported no to all three questions and those who re-
ported at least one definite asthma symptom was created.
Follow-up phenotypic information was available for 36/37
discordant twin pairs at age 18. Thirteen MZ twin pairs
discordant at age 10 remained discordant for asthma at
age 18. Twenty MZ twin pairs discordant at age 10 be-
came concordant unaffected at age 18, and three MZ twin
pairs became concordant affected at age 18.
Methylomic profiling
Genomic DNA (500 ng) was treated with sodium bisulfite
using the EZ-96 DNA Methylation Kit (Zymo Research,
CA, USA) following the manufacturers’ protocol. DNA
methylation was quantified using the Infinium Human-
Methylation450 BeadChip array (Illumina, Inc., San Diego,
CA) as previously described [24]. Each twin pair was proc-
essed together on the same array to avoid batch effects.
Genome Studio software (Illumina, Inc.) was used to ex-
tract signal intensities for each probe and perform initial
quality control. Further quality control checks, quantile
normalization and separate background adjustment of
methylated and unmethylated intensities of type I and II
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probes were employed using the wateRmelon package in
R (available from the bioconductor repository www.bio-
conductor.org) [24]. Samples with 5 % of sites with a de-
tection P value >.05 or a bead count <3 in 5 % of samples
were removed from the analysis. Non-specific probes
and probes on the X and Y chromosomes were re-
moved [62, 63]. The final analyses included 391,554
probes and included 31 asthma-discordant MZ pairs
(62 individual samples) at age 5, 37 MZ pairs (74 in-
dividual samples) at age 10, and 19 MZ (38 individual
samples) age-10 concordant unaffected pairs. Polymorphic
single nucleotide polymorphism control probes (n = 65)
located on the array were used to confirm monozygosity
for all twin pairs included in the final analysis.
Data analyses
All statistical analyses were performed using R statistical
package (version 3.1.1). Our primary analyses employed
a paired t test to identify DMPs between affected twins
(children who were reported as having a history of
asthma) and unaffected (children who had no reported
history of asthma) twin children using DNA collected at
age 10. Next, we identified a persistent-asthma sub-
group (13 MZ twin pairs) of asthma-discordant MZ
twins at age 10 who remained discordant for asthma at
age 18. A paired t test was employed to identify DMPs
between twins discordant (at both ages 10 and 18) for
asthma using DNA collected at age 10. Probes were
ranked according to P value. Analyses were repeated for
buccal samples collected at age 5. The Beta value (β) is a
ratio between methylated probe intensity and total probe
intensities (sum of methylated and unmethylated probe
intensities) and ranges from 0 to 1. Within the
persistent-asthma sub-group, intra-individual changes in
DNA methylation from ages 5 to 10 were calculated
(longitudinal Δβ) and the difference in longitudinal Δβ
between persistent-asthma-affected twins and their un-
affected co-twin was examined using a paired t test. An
empirical P value was calculated for top-ranked DMPs
(P < 0.0001) in both the asthma-discordant (n = 37 twin
pairs) and the persistent-asthma sub-group (n = 13 twin
pairs) by first randomly assigning twin status (affected/un-
affected) and performing a paired t test. This was repeated
for up to 10,000 permutations. An empirical P value was
calculated by dividing the number of permutations which
are at least as significant as the true result (P < 0.0001) by
the number of permutations performed.
The specificity of our persistent-asthma-associated
DMPs was determined by examining within-twin DNA
methylation differences at these loci in (i) an asthma-
remission sub-group (twins discordant for asthma at age
10 but the affected twin had remitted at 18, n = 20 twin
pairs) and (ii) concordant unaffected control MZ twins,
with no history of asthma in either twin (n = 19 twin
pairs). For the asthma-remission sub-group, the average
within-twin beta difference (Δβ) was calculated, at these
loci, by taking the average within-twin beta difference
(beta value of asthma-affected twin (age 10) − beta value
of unaffected co-twin (age 10)). For the concordant un-
affected control MZ twins, the average within-twin beta
difference, at these loci, was calculated using permuta-
tion testing (n = 1000). Briefly, concordant unaffected
twin pairs were randomly assigned a dichotomous vari-
able (0 (twin 1) or 1 (twin 2)) and the within-twin beta
difference (beta value of twin 1 − beta value of twin 2)
was calculated for each twin pair at each probe. Next,
the average within-twin beta difference (within-twin Δβ)
was calculated across all twin pairs at each probe, and
this was repeated 1000 times. The average within-twin
Δβ was calculated by taking the average of the permu-
tated within-twin Δβ values obtained at each DMP of
interest. The average within-twin Δβ was then compared
to (i) the average within-twin Δβ calculated from the
persistent-asthma-discordant MZ twin pairs and (ii) the
average within-twin Δβ calculated from the asthma-
remission group at each probe of interest using a one-way
analysis of variance (ANOVA). Post hoc pairwise compari-
sons (pairwise t test) were performed to identify which
groups were significantly different from each other.
Gene ontology term enrichment analysis
Gene ontology (GO) term enrichment analysis was per-
formed on genes annotated (Illumina UCSC gene anno-
tation) to age-10 DMPs, age-10 persistent-asthma DMPs
and longitudinal DMPs (nominal P < 0.001), respectively,
using the R package GOseqv1.18.1 (downloaded from
Bioconductor [64]). GOseq can be used to correct for
the number of Illumina 450K probes in each gene during
GO term enrichment analysis. The number of probes
per gene was calculated in our final dataset to create a
probability weighting function, which was then used in
the GO term enrichment analysis.
Additional files
Additional file 1: Figure S1. Flow chart describing the methodological
approach used in this study. Our analyses focused on identifying
differentially methylated positions (DMPs) associated with asthma in
(A) all asthma-discordant MZ twins at age 10 and (B) a sub-group
with persistent asthma who were discordant for asthma at age 10
and also at age 18. Using DNA previously collected at age 5, we (C)
subsequently assessed longitudinal changes in DNA methylation (between
ages 5 and 10) in persistent-asthma-discordant MZ twins. Finally, we (D)
examined epigenetic variation at top-ranked persistent-asthma-associated
DMPs in an asthma-remission group, comprising of MZ twin pairs
discordant for asthma at age 10 but concordant for no asthma
phenotype at 18 and concordant unaffected MZ twin pairs where
neither twin had asthma at both ages 10 and 18.
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Additional file 2: Tables S1–S7. Table S1. The top-ranked DMPs
(P < 0.001) in discordant MZ twin pairs at age 10. Table S2. Gene
ontology enrichment analysis for age-10 asthma-associated DMPs.
Table S3. The top-ranked DMPs at age 10 in persistent-asthma-discordant
MZ twins (between 10 and 18 years). Table S4. Gene ontology enrichment
analysis for persistent-asthma age-10 DMPs. Table S5. The top-ranked CpG
sites which show changes in DNA methylation levels between 5 and 10 years
of age in the asthma-discordant MZ twins. Table S6. Gene ontology
enrichment analysis of longitudinal DMPs between 5 and 10 years of
age. Table S7. Monozygotic twin group details.
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